LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

Daniels G. H.; Hegedus L.; Marso S. P.; Nauck M. A.; Zinman B.; Bergenstal R. M.; Mann J. F. E.; Karsbol J. Derving; Moses A. C.; Buse J. B.; Tuttle M.

首页> 外文期刊>Diabetes, obesity & metabolism >LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

【24h】

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

机译：领导者2：9340名2型糖尿病患者的降钙素基线水平参与了利拉鲁肽的治疗作用和作用：评估心血管结局结果（LEADER）试验：初步观察

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: To report preliminary data on baseline serum calcitonin concentrations and associated clinical characteristics in a global population with type 2 diabetes before liraglutide or placebo randomization.

机译：目的：在利拉鲁肽或安慰剂随机分组之前，报告全球2型糖尿病人群血清降钙素基线浓度和相关临床特征的初步数据。

著录项

来源
《Diabetes, obesity & metabolism》 |2015年第5期|共10页
作者
Daniels G. H.; Hegedus L.; Marso S. P.; Nauck M. A.; Zinman B.; Bergenstal R. M.; Mann J. F. E.; Karsbol J. Derving; Moses A. C.; Buse J. B.; Tuttle M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词
calcitonin; c-cell disease; diabetes; incretins;

机译：降钙素;c细胞疾病;糖尿病;肠促胰岛素;

相似文献

外文文献
中文文献
专利

1. LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations [J] . Daniels G. H., Hegedus L., Marso S. P., Diabetes, obesity & metabolism . 2015,第5期

机译：领导者2：9340名2型糖尿病患者的降钙素基线水平参与了利拉鲁肽的治疗作用和作用：评估心血管结局结果（LEADER）试验：初步观察
2. Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial [J] . Crowley Matthew J., McGuire Darren K., Alexopoulos Anastasia-Stefania, Diabetes care . 2020,第9期

机译：Liraglutide对2型糖尿病患者心血管结果的影响，无基线二甲双胍使用：领导者试验后HOC分析
3. Follow the LEADER-Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial [J] . Sanjay Kalra Diabetes therapy . 2016,第4期

机译：遵循糖尿病的领导者 - Liraglutide效应和作用：心血管结果结果评估
4. Rationale, Design and Preliminary Results of ROMEO (Rethink Organization to Improve Education and Outcomes) A Randomized Controlled Multicenter Trial of Group Care in the Management ofType 1 Diabetes [C] . M. Porta, M. Trent European Association for the Study of Diabetes . 2005

机译：Romeo（重新思考组织改善教育和结果）的基本理由，设计和初步结果，在1型糖尿病的术语中进行了随机对照的组织的多中心试验
5. Barriers to physical activity in people with type 2 diabetes mellitus enrolled in a worksite disease management program [D] . Erickson, Deborah L. 2008

机译：参加工作场所疾病管理计划的2型糖尿病患者的身体活动障碍
6. LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations [O] . G H Daniels, L Hegedüs, S P Marso, -1

机译：领导者2：9340名2型糖尿病患者的降钙素基线水平参与了利拉鲁肽的治疗作用和作用：评估心血管结局结果（LEADER）试验：初步观察
7. LEADER 2:baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations [O] . Daniels, G H, Hegedüs, L, Marso, S P, 2015

机译：领先者2：基线降钙素在9340名2型糖尿病患者中参与了利拉鲁肽的作用和对糖尿病的作用：评估心血管结局结果（LEADER）试验：初步观察

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations

摘要

著录项

相似文献

相关主题

期刊订阅